144 related articles for article (PubMed ID: 26897854)
21. Measurement of lysophospholipase D/autotaxin activity in human serum samples.
Nakamura K; Ohkawa R; Okubo S; Tozuka M; Okada M; Aoki S; Aoki J; Arai H; Ikeda H; Yatomi Y
Clin Biochem; 2007 Feb; 40(3-4):274-7. PubMed ID: 17222397
[TBL] [Abstract][Full Text] [Related]
22. Autotaxin and LPA receptor signaling in cancer.
Houben AJ; Moolenaar WH
Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
[TBL] [Abstract][Full Text] [Related]
23. [Function and biological activities of the autotaxin-LPA axis].
Li ZW; Zhao YR; Zhao C; Fu R; Li ZY
Sheng Li Xue Bao; 2011 Dec; 63(6):601-10. PubMed ID: 22193457
[TBL] [Abstract][Full Text] [Related]
24. The Role of Autotaxin and LPA Signaling in Embryonic Development, Pathophysiology and Cancer.
Magkrioti C; Kaffe E; Aidinis V
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176032
[TBL] [Abstract][Full Text] [Related]
25. Lack of significant differences in the corrected activity of lysophospholipase D, producer of phospholipid mediator lysophosphatidic acid, in incubated serum from women with and without ovarian tumors.
Tokumura A; Tominaga K; Yasuda K; Kanzaki H; Kogure K; Fukuzawa K
Cancer; 2002 Jan; 94(1):141-51. PubMed ID: 11815970
[TBL] [Abstract][Full Text] [Related]
26. Structure-function relationships of autotaxin, a secreted lysophospholipase D.
Hausmann J; Perrakis A; Moolenaar WH
Adv Biol Regul; 2013 Jan; 53(1):112-7. PubMed ID: 23069371
[TBL] [Abstract][Full Text] [Related]
27. Serum autotaxin is not a useful biomarker for ovarian cancer.
Nakamura K; Igarashi K; Ohkawa R; Yokota H; Masuda A; Nakagawa S; Yano T; Ikeda H; Aoki J; Yatomi Y
Lipids; 2012 Sep; 47(9):927-30. PubMed ID: 22700442
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells.
Brünnert D; Sztachelska M; Bornkessel F; Treder N; Wolczynski S; Goyal P; Zygmunt M
Mol Hum Reprod; 2014 Oct; 20(10):1016-25. PubMed ID: 24994816
[TBL] [Abstract][Full Text] [Related]
29. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood.
Sano T; Baker D; Virag T; Wada A; Yatomi Y; Kobayashi T; Igarashi Y; Tigyi G
J Biol Chem; 2002 Jun; 277(24):21197-206. PubMed ID: 11929870
[TBL] [Abstract][Full Text] [Related]
30. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.
van Meeteren LA; Ruurs P; Stortelers C; Bouwman P; van Rooijen MA; Pradère JP; Pettit TR; Wakelam MJ; Saulnier-Blache JS; Mummery CL; Moolenaar WH; Jonkers J
Mol Cell Biol; 2006 Jul; 26(13):5015-22. PubMed ID: 16782887
[TBL] [Abstract][Full Text] [Related]
31. Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy.
Tokumura A; Kanaya Y; Miyake M; Yamano S; Irahara M; Fukuzawa K
Biol Reprod; 2002 Nov; 67(5):1386-92. PubMed ID: 12390867
[TBL] [Abstract][Full Text] [Related]
32. Lysophospholipase D and its role in LPA production.
Xie Y; Meier KE
Cell Signal; 2004 Sep; 16(9):975-81. PubMed ID: 15212758
[TBL] [Abstract][Full Text] [Related]
33. Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity.
Hosogaya S; Yatomi Y; Nakamura K; Ohkawa R; Okubo S; Yokota H; Ohta M; Yamazaki H; Koike T; Ozaki Y
Ann Clin Biochem; 2008 Jul; 45(Pt 4):364-8. PubMed ID: 18583620
[TBL] [Abstract][Full Text] [Related]
34. Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome.
Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Kishimoto T; Miyazaki T; Nishino A; Nakajima N; Yaginuma K; Tamura H; Kojima T; Yokoyama K; Kurata T; Shimada K; Yatomi Y; Daida H
Clin Chim Acta; 2012 Jan; 413(1-2):207-12. PubMed ID: 21983165
[TBL] [Abstract][Full Text] [Related]
35. A 3D view of autotaxin.
Nishimasu H; Ishitani R; Aoki J; Nureki O
Trends Pharmacol Sci; 2012 Mar; 33(3):138-45. PubMed ID: 22277299
[TBL] [Abstract][Full Text] [Related]
36. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
Samadi N; Bekele R; Capatos D; Venkatraman G; Sariahmetoglu M; Brindley DN
Biochimie; 2011 Jan; 93(1):61-70. PubMed ID: 20709140
[TBL] [Abstract][Full Text] [Related]
37. Autotaxin and lysophospholipids in rheumatoid arthritis.
Bourgoin SG; Zhao C
Curr Opin Investig Drugs; 2010 May; 11(5):515-26. PubMed ID: 20419597
[TBL] [Abstract][Full Text] [Related]
38. Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta.
Iwasawa Y; Fujii T; Nagamatsu T; Kawana K; Okudaira S; Miura S; Matsumoto J; Tomio A; Hyodo H; Yamashita T; Oda K; Kozuma S; Aoki J; Yatomi Y; Taketani Y
Am J Reprod Immunol; 2009 Aug; 62(2):90-5. PubMed ID: 19614625
[TBL] [Abstract][Full Text] [Related]
39. Analysis of serum and urinary lysophospholipase D/autotaxin in nephrotic syndrome.
Nakamura K; Nangaku M; Ohkawa R; Okubo S; Yokota H; Ikeda H; Aoki J; Yatomi Y
Clin Chem Lab Med; 2008; 46(1):150-1. PubMed ID: 18034642
[No Abstract] [Full Text] [Related]
40. Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids.
Nakamura K; Kishimoto T; Ohkawa R; Okubo S; Tozuka M; Yokota H; Ikeda H; Ohshima N; Mizuno K; Yatomi Y
Anal Biochem; 2007 Aug; 367(1):20-7. PubMed ID: 17568554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
